Pages that link to "Q41715223"
Jump to navigation
Jump to search
The following pages link to Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication (Q41715223):
Displaying 50 items.
- Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies (Q24568329) (← links)
- Crystal structure of an RNA aptamer bound to thrombin (Q24652403) (← links)
- Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL (Q24793909) (← links)
- Targeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei. (Q24810050) (← links)
- Bone Marrow Gene Therapy for HIV/AIDS (Q26801765) (← links)
- Nucleic acid aptamers: an emerging frontier in cancer therapy (Q26849947) (← links)
- Utilization of heterologous alphavirus junction sequences as promoters by Sindbis virus (Q27486214) (← links)
- Inhibition of west nile virus replication by retrovirus-delivered small interfering RNA in human neuroblastoma cells (Q27490949) (← links)
- Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex (Q27651054) (← links)
- Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge (Q27733920) (← links)
- Emerging clinical applications of RNA (Q28214164) (← links)
- A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1 (Q28260418) (← links)
- Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein (Q28379462) (← links)
- Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor (Q30463953) (← links)
- Aptamers and their biological applications (Q30470240) (← links)
- Bi-functional, substrate mimicking RNA inhibits MSK1-mediated cAMP-response element-binding protein phosphorylation and reveals magnesium ion-dependent conformational changes of the kinase (Q30848680) (← links)
- Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy. (Q33541775) (← links)
- Gene therapy for AIDS. (Q33579411) (← links)
- Genetic engineering for xenotransplantation (Q33636597) (← links)
- Strategies to express structural and catalytic RNAs in mammalian cells (Q33702807) (← links)
- Genetic strategies to inhibit HIV. (Q33739314) (← links)
- Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics (Q33830704) (← links)
- HIV protease as a target for retrovirus vector-mediated gene therapy (Q33857478) (← links)
- Gene therapy for infectious diseases (Q33992464) (← links)
- Nucleic acid aptamers: clinical applications and promising new horizons (Q34028112) (← links)
- Multiple biological roles associated with the repeat (R) region of the HIV-1 RNA genome (Q34033118) (← links)
- Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs. (Q34042038) (← links)
- A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo (Q34159206) (← links)
- Tat-independent replication of human immunodeficiency viruses (Q34195783) (← links)
- Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector (Q34200458) (← links)
- Gene therapy for HIV. (Q34208320) (← links)
- Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells (Q34244510) (← links)
- In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1. (Q34362307) (← links)
- Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes (Q34365376) (← links)
- A nucleolar TAR decoy inhibitor of HIV-1 replication. (Q34391750) (← links)
- Development of universal antidotes to control aptamer activity. (Q34433842) (← links)
- RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production (Q34457815) (← links)
- RNA-based gene therapy for HIV infection (Q34459382) (← links)
- Fusion with an RNA binding domain to confer target RNA specificity to an RNase: design and engineering of Tat-RNase H that specifically recognizes and cleaves HIV-1 RNA in vitro (Q34595695) (← links)
- Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells (Q34634265) (← links)
- Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication (Q34669645) (← links)
- Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter. (Q34757765) (← links)
- Stem cell-based anti-HIV gene therapy (Q34769333) (← links)
- Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses (Q34961807) (← links)
- Selective optimization of the Rev-binding element of HIV-1. (Q35019143) (← links)
- Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments (Q35059839) (← links)
- Aptamers: active targeting ligands for cancer diagnosis and therapy (Q35086493) (← links)
- Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells (Q35142045) (← links)
- Correlations Between theIn VitroandIn VivoActivity of Anti-HIV Agents: Implications for Future Drug Deyelopment (Q35174403) (← links)
- A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection (Q35189274) (← links)